We propose to design and test systems for the ablation of pancreatic cancer and other retroperitoneal malignancies using magnetic resonance thermal imaging (MRTI) within a 3 Tesla magnetic resonance. We will design and test ultrasonic delivery systems using ultrasonic applicators directly inserted into tumors ("interstitial" applicators), as well as an existing ultrasonic array system external to the body. Additionally, we will develop MRI-based 3-dimensional techniques for patient specific treatment planning, and robust MRTI techniques for monitoring retroperitoneal tumor ablation. In vivo studies using an animal model will allow determination of MRTI accurately to portray tissue ablation in real time, and avoid damage to normal structures adjacent to tumors. The in vivo studies of acute and longer-term changes to tissues during ablation will also investigate several types of MR imaging, including T2-weighted, diffusion weighted, contrast- enhanced and MR images encoding tissue stiffness, following ablative procedures. Histologic/MRI correlations will allow for determination of the ability of such images accurately to portray tissue changes resulting from the ablative procedures. The clinical importance of the project stems from the fact that the major cancer targeted, pancreatic cancer is currently the fourth leading cause of cancer death in the United States;it is nearly uniformly fatal, since early local extension with encasement of blood vessels makes surgery impossible in about 90% of cases, and other treatment modalities are of limited effectiveness. The controlled thermal techniques proposed should be capable of ablating cancers extending to blood vessels, which cannot be treated surgically. The technologies and techniques, to be developed should allow effective treatment of pancreatic cancer and other retroperitoneal malignancies with minimal damage to normal structures and minimal side effects of treatment.
Pancreatic cancer is currently the fourth leading cause of cancer death in the United States, and treatment is generally of very limited effectiveness. We propose the development and extensive testing of systems for the thermal destruction of pancreatic and other retroperitoneal cancers using guidance available with MR imaging to visualize the heating process during treatment, and evaluate tissue damage following treatment. We will develop systems capable of effective minimally invasive treatment of such malignancies, while sparing normal tissues and improving patient outcomes.
|Ellenor, Christopher W; Stang, Pascal P; Etezadi-Amoli, Maryam et al. (2015) Offline impedance measurements for detection and mitigation of dangerous implant interactions: an RF safety prescreen. Magn Reson Med 73:1328-39|
|Etezadi-Amoli, Maryam; Stang, Pascal; Kerr, Adam et al. (2015) Interventional device visualization with toroidal transceiver and optically coupled current sensor for radiofrequency safety monitoring. Magn Reson Med 73:1315-27|
|Scott, Serena J; Salgaonkar, Vasant; Prakash, Punit et al. (2014) Interstitial ultrasound ablation of vertebral and paraspinal tumours: parametric and patient-specific simulations. Int J Hyperthermia 30:228-44|
|Vyas, Urvi; Kaye, Elena; Pauly, Kim Butts (2014) Transcranial phase aberration correction using beam simulations and MR-ARFI. Med Phys 41:032901|
|Bitton, Rachel R; Pauly, Kim R Butts (2014) MR-acoustic radiation force imaging (MR-ARFI) and susceptibility weighted imaging (SWI) to visualize calcifications in ex vivo swine brain. J Magn Reson Imaging 39:1294-300|
|Rube, Martin A; Holbrook, Andrew B; Cox, Benjamin F et al. (2014) Wireless MR tracking of interventional devices using phase-field dithering and projection reconstruction. Magn Reson Imaging 32:693-701|
|Prakash, Punit; Salgaonkar, Vasant A; Diederich, Chris J (2013) Modelling of endoluminal and interstitial ultrasound hyperthermia and thermal ablation: applications for device design, feedback control and treatment planning. Int J Hyperthermia 29:296-307|
|Rieke, Viola; Instrella, Ron; Rosenberg, Jarrett et al. (2013) Comparison of temperature processing methods for monitoring focused ultrasound ablation in the brain. J Magn Reson Imaging 38:1462-71|
|Sommer, Graham; Pauly, Kim Butts; Holbrook, Andrew et al. (2013) Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia. Invest Radiol 48:387-94|
|Sommer, Graham; Bouley, Donna; Gill, Harcharan et al. (2013) Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance. Can J Urol 20:6672-81|
Showing the most recent 10 out of 11 publications